Physician
Pathology Associates of Arcadia
Pathology Associates of Arcadia was paid $452K by Medicaid between Jan 2018 and Aug 2024, across 69 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 16% of everything it billed.
33Billing provider infoPATHOLOGY ASSOCIATES OF ARCADIA
PASADENA, CA 91105
PASADENA, CA 91105
33aNPI1659633493assigned 06/07/2012
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$452K
24GClaims270,774
24DCodes billed69
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#60 of 222
Median peer was paid$42K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,000 | $48K | |
| 2019 | 45,391 | $52K | |
| 2020 | 33,717 | $42K | |
| 2021 | 32,847 | $52K | |
| 2022 | 43,822 | $74K | |
| 2023 | 52,141 | $130K | |
| 2024incomplete | 26,856 | $55K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 16% | 2,567 | 2,467 | $72K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 13% | 13,341 | 3,141 | $58K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.2% | 6,179 | 5,694 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.7% | 42,439 | 24,873 | $39K |
| 80053 | Comprehensive metabolic panel | 7.4% | 30,283 | 22,258 | $33K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5.2% | 2,374 | 1,264 | $24K |
| 82948 | 5.0% | 27,838 | 4,069 | $23K | |
| 81001 | 3.5% | 15,509 | 14,346 | $16K | |
| 84484 | 3.3% | 13,700 | 10,040 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.2% | 12,669 | 5,377 | $14K |
| 83880 | 3.0% | 4,274 | 3,672 | $14K | |
| 88312 | 2.9% | 813 | 803 | $13K |
57 more codes
| 87040 | 2.3% | 6,274 | $10K | |
| 83690 | 1.5% | 9,556 | $7K | |
| 83605 | 1.4% | 4,453 | $6K | |
| 84703 | 1.3% | 9,423 | $6K | |
| 83735 | 1.1% | 6,223 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.0% | 958 | $5K |
| 85610 | <1% | 9,612 | $4K | |
| 86710 | <1% | 3,853 | $4K | |
| 87186 | <1% | 3,017 | $3K | |
| 87088 | <1% | 4,903 | $3K | |
| 85576 | <1% | 1,016 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,694 | $3K |
| 80061 | Lipid panel | <1% | 1,782 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,053 | $2K |
| 88307 | <1% | 41 | $2K | |
| 85730 | <1% | 2,740 | $2K | |
| 84100 | <1% | 3,067 | $2K | |
| 86756 | <1% | 1,206 | $1K | |
| 84702 | <1% | 1,085 | $1K | |
| 87070 | <1% | 1,262 | $1K | |
| 86900 | <1% | 3,353 | $1K | |
| 86901 | <1% | 3,368 | $1K | |
| 85379 | <1% | 1,353 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 315 | $1K |
| 86886 | <1% | 1,678 | $1K | |
| 86920 | <1% | 397 | $821.29 | |
| 86140 | <1% | 1,112 | $754.84 | |
| 87205 | <1% | 1,133 | $707.96 | |
| 80320 | <1% | 1,591 | $670.97 | |
| 82728 | <1% | 466 | $645.17 | |
| 85651 | <1% | 1,296 | $573.29 | |
| 81003 | <1% | 2,007 | $525.03 | |
| 87641 | <1% | 125 | $408.67 | |
| 88304 | <1% | 37 | $406.97 | |
| 80329 | <1% | 928 | $372.38 | |
| 82550 | <1% | 419 | $353.73 | |
| 84145 | <1% | 103 | $352.55 | |
| 81025 | <1% | 401 | $344.70 | |
| 81002 | <1% | 1,633 | $329.63 | |
| 82607 | <1% | 192 | $320.24 | |
| 86850 | <1% | 849 | $308.58 | |
| 83615 | <1% | 251 | $166.48 | |
| 83550 | <1% | 193 | $162.83 | |
| 82746 | <1% | 127 | $154.49 | |
| 83540 | <1% | 187 | $145.78 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $124.06 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 38 | $123.66 |
| 82140 | <1% | 78 | $110.97 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 631 | $72.78 |
| 80076 | <1% | 74 | $62.53 | |
| 80074 | <1% | 39 | $50.33 | |
| 84460 | <1% | 71 | $34.83 | |
| 84439 | <1% | 19 | $26.32 | |
| 87449 | <1% | 26 | $16.80 | |
| 82565 | <1% | 13 | $8.94 | |
| 87210 | <1% | 13 | $4.24 | |
| 80354 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHANDRASOMA, PARAKRAMA (OWNER / PHYSICIAN)
| Provider | Location | Paid |
|---|---|---|
| Parakrama T Chandrasoma MD a Medical Corporation | Pasadena, CA | $28K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.